The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
have no idea , company is debt free , cash in bank , turnover and pretax profit projections slightly down for the future.
If it was in Debt and not making a profit then the share would rocket ; its a mad world in shares
All looks good here but why is the market cap so low?
Dont forget the 12$mil arbitration claim the Ukraine as well massively undervalued
good update. key is that there is nothing spectacular on the negative side. If I do a quick calculation on say approx average figures between Q1 and Q2 we are good for around $ 61 M revenue for this year which is around 40% less than reported 2019 revenue of $ 101.7 M. This will mean around $15 M profit for the year. I assumed production slightly less than 11K they said they currently have and have assumed lower oil price of $35. I have not included any major increase in gas prices. If these increase by end of the year and overall boe is maintained at around 11k figures could be closer to $80M+. So how do we value JKX based on these figures 2.5 x profit with no debt and no cash of $14.5M + $1.7M (oil stock) included in the valuation. Surely this is worth at least double that even without predicted recovery in gas prices?
OK update. Cash balance is flat over 3 months, 2 months-ish until the results of the case, and might not get the $11.8m back anyway. Unfortunately, I've found through personal experience that Investor relations are very poor here and needs to be improved. continue to hold but with less conviction than before. stale bull seems to be offloading on any rise.
40 pence by mid October anyway start of winter period , with the reduce spending on gas projects the price should be 20% then last year prices
No debt, EV of sub £20m and producing in excess 10kboepd equivilent. Just need the gas price to kick up a notch or two and Rocket's could be in order...small mcap for what we have. Was 40p and we will be heading back there by the end of the year